KAM
INFI

Knightsbridge Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Knightsbridge Asset Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,719
Closed -$14K – 125
2022
Q1 		$14K Buy
+12,719
New +$15.2K ﹤0.01% 98
2021
Q2 		– Sell
-173,110
Closed -$559K – 70
2021
Q1 		$559K Buy
+173,110
New +$578K 0.24% 42

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Knightsbridge Asset Management's INFI Position: Q2 2022 in Review

Knightsbridge Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 12,719 shares — an estimated $14K sold.

Knightsbridge Asset Management first reported a position in INFI in Q1 2021 and held it in 2 quarters. The position peaked at $559K in Q1 2021. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

  • Knightsbridge Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Knightsbridge Asset Management sold 12,719 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $14K.
  • Knightsbridge Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2021 and held it in 2 quarters.
  • Knightsbridge Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $559K in Q1 2021.
  • 77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on Knightsbridge Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.